My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
RES-2022-168
>
Meetings
>
2022
>
09. September
>
2022-09-06 10:00 AM - Commissioners' Agenda
>
RES-2022-168
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/13/2022 11:54:56 AM
Creation date
9/13/2022 11:53:49 AM
Metadata
Fields
Template:
Meeting
Date
9/6/2022
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Resolution Authorizing the Chair's Signature on a Opioid Litigation Allocation Agreement
Order
3
Placement
Consent Agenda
Row ID
93293
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
107
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
17. Develop or support a National Treatment Availability Clearinghouse a <br />multistate/nationally accessible database whereby health care providers can list <br />locations for currently available in-patient and out-patient OUD treatment services <br />that are accessible on a real-time basis by persons who seek treatment. <br />D. ADDRESS THE NEEDS OF CRIMIN AL.JUSTICE.INVOLVED PERSONS <br />Address the needs of persons with OUD and any co-occurring SUD/MH conditions, co- <br />usage, and/or co-addiction who are involved - or are at risk of becoming involved - in the <br />criminal justice system through evidence-based, evidence-informed, or promising programs <br />or strategies that may include, but are not limited to, the following: <br />l. Support pre-arrest or post-arrest diversion and deflection strategies for persons with <br />OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, <br />including established strategies such as: <br />a. Self-referral strategies such as the Angel Programs or the Police Assisted <br />Addiction Recovery Initiative (PAARI); <br />b. Active outreach strategies such as the Drug Abuse Response Team (DART) <br />model; <br />c. "Naloxone Plus" strategies, which work to ensure that individuals who have <br />received naloxone to reverse the effects of an overdose are then linked to <br />treatment programs or other appropriate services; <br />d. Officer prevention strategies, such as the Law Enforcement Assisted Diversion <br />(LEAD) model; <br />e. Officer intervention strategies such as the Leon County, Florida Adult Civil <br />Citation Network or the Chicago Westside Narcotics Diversion to Treatment <br />Initiative; <br />f. Co-responder and/or altemative responder models to address OUD-related 911 <br />calls with greater SUD expertise and to reduce perceived barriers associated with <br />law enforcement 911 responses; or <br />g. County prosecution diversion programs, including diversion officer salary, only <br />for counties with a population of 50,000 or less. Any diversion services in matters <br />involving opioids must include drug testing, monitoring, or treatment. <br />2. Support pre-trial services that connect individuals with OUD and any co-occurring <br />SUD/MH conditions, co-usage, and/or co-addiction to evidence-informed treatment, <br />including MAT, and related services. <br />3. Support treatment and recovery courts for persons with OUD and any co-occurring <br />SUD/MH conditions, co-usage, andlor co-addiction, but only if these courts provide <br />referrals to evidence-informed treatment, including MAT. <br />5
The URL can be used to link to this page
Your browser does not support the video tag.